arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Illumina, Inc.

ILMN Health Care Medical Specialities
$220.00
▲ +0.8% Today
as of Sep 4, 16:50 ET
Last 30 days +13.08% Jul 28 → Sep 04
$184.78 $196.30 $207.83 $219.35 $230.87 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$216.74
High
$219.57
Low
$213.95
Volume
$2M
Avg Vol
$2M
Mkt Cap
$29.3B
P/E (TTM)
68.19
Beta
—
52w High
$231.81
52w Low
$88.00
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 24 ▼ 0
Sep 5 · 05:05 Simply Wall St. neutral
Could Illumina’s Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)?
Sep 4 · 23:42 Stocktwits neutral
BE, P, ILMN Join S&P 500; LNG Misses Out — Bloom Energy Stock Gains While Cheniere Energy Slips
Sep 4 · 23:15 PR PR Newswire neutral
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$88
$232
92% of range
Avg surprise (last 2)
+8.9%
Avg reaction (last 1)
+4.2%
100% positive
Latest IV / EM
46%
EM ±7.2% · $220 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-12.48$-8.26$-4.03$0.19$4.42 Actual $-1.48Actual $-4.77Actual $-0.79Actual $-12.48Actual $4.42Actual $0.97Est $0.96Actual $1.19Est $1.02Actual $0.98Actual $0.87Actual $1.35 JulOctMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$304M$608M$913M$1.2B Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sun Jun 28, 2026Jun 2026 $1.35 — — — — financials
Sun Mar 29, 2026Mar 2026 $0.87 — — — — financials
Sun Sep 28, 2025Sep 2025 $0.98 — — — — financials
Thu Jul 31, 2025Jun/2025 $1.19 $1.02 +16.7% — — earnings
Thu May 8, 2025Mar/2025 $0.97 $0.96 +1.0% — +4.2% earnings
Sun Sep 29, 2024Sep 2024 $4.42 — — — — financials
Sun Jun 30, 2024Jun 2024 $-12.48 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.79 — — — — financials
Sun Oct 1, 2023Oct 2023 $-4.77 — — — — financials
Sun Jul 2, 2023Jul 2023 $-1.48 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.16B$1.09B—$1.08B$1.06B$1.04B—$1.08B
Cost of revenue$389M$370M—$351M$364M$358M—$335M
Gross profit$770M$721M—$733M$695M$683M—$745M
Operating income$245M$209M—$227M$214M$164M—$741M
Net income$207M$134M$334M$150M$235M$131M$186M$705M
EPS (diluted)$1.35$0.87—$0.98$1.49$0.82—$4.42

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents————————
Inventory$629M$611M$564M$590M$575M$537M—$574M
Total current assets$2.83B$2.74B$3.29B$2.80B$2.64B$2.67B—$2.37B
Total assets$6.65B$6.56B$6.64B$6.18B$6.09B$6.18B—$6.01B
Long-term debt————————
Total liabilities————————
Total equity$2.84B$2.68B$2.72B$2.38B$2.26B$2.37B$2.37B$2.12B

Implied volatility — last 90 days

34%50%66%83%99% Jun 07 — IV 54% · EM ±7.4%Jun 08 — IV 50% · EM ±6.5%Jun 09 — IV 47% · EM ±5.8%Jun 10 — IV 51% · EM ±6.0%Jun 11 — IV 44% · EM ±4.9%Jun 12 — IV 42% · EM ±4.3%Jun 15 — IV 48% · EM ±3.4%Jun 16 — IV 51% · EM ±3.0%Jun 17 — IV 74% · EM ±3.1%Jun 19 — IV 41% · EM ±9.0%Jun 22 — IV 41% · EM ±8.6%Jun 23 — IV 42% · EM ±8.6%Jun 24 — IV 46% · EM ±9.3%Jun 25 — IV 43% · EM ±8.4%Jun 26 — IV 43% · EM ±8.2%Jun 29 — IV 44% · EM ±7.8%Jun 30 — IV 40% · EM ±6.9%Jul 01 — IV 46% · EM ±7.6%Jul 02 — IV 44% · EM ±7.0%Jul 03 — IV 45% · EM ±7.0%Jul 06 — IV 49% · EM ±6.7%Jul 07 — IV 45% · EM ±5.9%Jul 08 — IV 48% · EM ±6.0%Jul 09 — IV 43% · EM ±5.1%Jul 10 — IV 43% · EM ±4.8%Jul 13 — IV 53% · EM ±4.4%Jul 14 — IV 49% · EM ±3.5%Jul 15 — IV 51% · EM ±3.0%Jul 16 — IV 57% · EM ±2.4%Jul 20 — IV 53% · EM ±12.6%Jul 21 — IV 56% · EM ±12.9%Jul 22 — IV 50% · EM ±11.5%Jul 23 — IV 57% · EM ±12.8%Jul 24 — IV 52% · EM ±11.5%Jul 27 — IV 58% · EM ±12.2%Jul 28 — IV 59% · EM ±12.1%Jul 29 — IV 61% · EM ±12.3%Jul 30 — IV 60% · EM ±11.7%Jul 31 — IV 48% · EM ±9.1%Aug 03 — IV 47% · EM ±8.3%Aug 04 — IV 47% · EM ±8.0%Aug 05 — IV 43% · EM ±7.2%Aug 06 — IV 45% · EM ±7.3%Aug 07 — IV 41% · EM ±6.4%Aug 10 — IV 45% · EM ±6.3%Aug 11 — IV 41% · EM ±5.4%Aug 12 — IV 43% · EM ±5.4%Aug 13 — IV 40% · EM ±4.8%Aug 14 — IV 34% · EM ±3.8%Aug 17 — IV 50% · EM ±4.2%Aug 18 — IV 45% · EM ±3.3%Aug 19 — IV 100% · EM ±5.9%Aug 20 — IV 76% · EM ±3.2%Aug 24 — IV 48% · EM ±9.9%Aug 25 — IV 48% · EM ±9.8%Aug 26 — IV 48% · EM ±9.7%Aug 27 — IV 47% · EM ±9.2%Aug 28 — IV 48% · EM ±9.2%Aug 31 — IV 50% · EM ±8.8%Sep 01 — IV 47% · EM ±8.1%Sep 02 — IV 48% · EM ±8.0%Sep 03 — IV 47% · EM ±7.5%Sep 04 — IV 46% · EM ±7.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in